Microgram Notes: The DEA Mid-Atlantic Laboratory (Largo, Maryland) recently received 705 yellow tablets with a Superman logo, suspected MDMA (see Photo 6). The exhibits were seized at a mail distribution facility in Norfolk, Virginia by the Norfolk Police. Analysis of the tablets (total net mass 198.1 grams) by GC/MS, TLC, and GC confirmed MDMA (10.9 milligrams/tablet), adulterated with methamphetamine (6.1 milligrams/tablet), N-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl)-piperazine (TFMPP), dibenzylpiperazine, caffeine, and procaine. The three piperazines were not quantitated; however, based on the TIC and GC, the BZP and TFMPP were both higher in concentration than the MDMA and methamphetamine. The tablets also contained MDP2P and piperonal (both indicative of the MDMA synthesis route). The Mid-Atlantic Laboratory has seen a wide variety of Ecstasy combination tablets containing both MDMA and methamphetamine, and a few Ecstasy-mimic tablets containing BZP and TFMPP mixtures, but this is believed to be the first such submission containing all four of these drugs.
Send in a sample for testing
DrugsData tests all psychoactive drugs including ecstasy tablets, powders, research chemicals, novel pschoactive substances, and other drugs through our licensed laboratory. Ecstasy/Molly tablets cost $100. Recreational drug powder/crystal/blotter costs $100. Pharmaceuticals, supplements and all others cost $150 per analysis.
Should the public have access to independent analysis of the products they consume?
The vast majority of analyses of over-the-counter, prescription, and recreational drugs are performed in secret with no independent oversite or review. No other historical record, free from politically-controlled agencies, is currently available in North America nor most other parts of the world.
DrugsData, a project of Erowid Center, needs the support of professionals, students, parents, individuals with means, and small foundations for a total yearly budget of around $120,000 USD. Erowid Center's general budget and the co-pays we require fund most of this cost.